Galectins have emerged as potent immunoregulatory molecules that control chronic inflammation through distinct mechanisms. Galectin-8 (Gal-8), a tandem-repeat type galectin with unique preference for α2,3-sialylated glycans, is ubiquitously expressed, but little is known about its role in T cell differentiation. Here, we report that Gal-8 promotes the polyclonal differentiation of primary mouse Treg cells in vitro. We further show that Gal-8 also facilitates antigen-specific differentiation of regulatory T (Treg) cells, and that Treg cells polarized in the presence of Gal-8 express cytotoxic T lymphocyte antigen-4 (CTLA-4) and IL-10 at a higher frequency than control Treg cells, and efficiently inhibit proliferation of activated T cells in vitro. Investigation of the mechanism by which Gal-8 promotes Treg conversion revealed that Gal-8 activates TGFβ signaling and promotes sustained IL-2R signaling. Taken together, these data suggest that Gal-8 promotes the differentiation of highly suppressive Treg cells, which has implications for the treatment of inflammatory and autoimmune diseases.
Introduction
Regulatory T (Treg) cells are crucial suppressors of immune responses and are essential for maintaining immunological tolerance and homeostasis. Forkhead box P3 (Foxp3) is the master transcription factor of Treg cells and plays a central role in the development and function of these cells. 1 The pivotal role of Treg cells in controlling autoimmunity is underscored by the lethal autoimmune disease in mice that lack Treg cells due to inherited mutations in Foxp3. 2 Treg cells suppress effector T cell responses during infection, inflammation, and autoimmunity through several mechanisms, including expression of cytotoxic T lymphocyte antigen (CTLA)-4, which prevents T cells from receiving costimulatory signals from activated APCs. 3 Treg cells also secrete the pleiotropic immunosuppressive cytokine, IL-10, to limit immune responses; this mechanism has been shown to be particularly important in preventing immunopathology in tissues that have direct contact with the external environment, such as the eye and the gut, 4 and inhibiting autoimmune diseases. 5 Due to the key role of Treg cells in preventing autoimmunity, there is intense interest in manipulating the signals responsible for generating and maintaining these cells. Although the generation and regulation of Treg cells is a complex and incompletely understood process, it is known that Treg cell development in the periphery depends on IL-2 and TGFβ signaling. 1 Recent studies have provided evidence that members of the galectin family also have the potential to modulate the generation and stability of Treg cells. 6 , 9 Galectins are a family of β-galactoside-binding animal lectins that regulate diverse biological processes including, but not limited to, immune homeostasis, pathogen recognition, neurogenesis, and vascular permeability. 10 , 13 Recently, galectins have emerged as potential therapeutic agents for chronic inflammatory conditions such as autoimmunity and infection because of increasing evidence demonstrating their role in the regulation of both the innate and adaptive immune systems. 10 Gal-1 and -9 enhance the frequency and immunosuppressive capacity of Treg cells, 8 , 14 whereas Gal-3 inhibits Treg cell conversion and function. 15 Gal-8 is a tandem-repeat type galectin, composed of two structurally distinct carbohydrate recognition domains (CRDs) connected by a short peptide linker. The Nterminal CRD of Gal-8 preferentially binds to α2,3-sialylated glycans, a unique specificity among galectins. 16 Although the expression of Gal-8 is ubiquitous and markedly increased in response to inflammation (Chen, et al. in preparation), its role in the regulation of the immune system is poorly understood, and in particular little is known about the role of Gal-8 in the regulation of Treg cell differentiation and function. We have recently demonstrated that Gal-8 promotes Treg differentiation and ameliorates murine autoimmune uveitis pathology. 17 We demonstrate here that Gal-8 enhances Treg and T H 2 differentiation and kills T H 17 cells. We further show that a higher percentage of Treg cells polarized in the presence of Gal-8 express the inhibitory coreceptor CTLA-4 and the immunosuppressive cytokine IL-10, as compared to control Treg cells, and that Gal-8-polarized Treg cells are potent suppressors of activated T cells in vitro. Efforts to characterize the mechanism by which Gal-8 promotes
Treg cell differentiation revealed that this lectin binds to TGFβRII as well as IL-2Rβ, activating the TGFβ signaling pathway and sustaining IL-2 signaling. (Fig. 1A, 1B) ; at the highest concentration tested, Treg and T H 2 cell differentiation increased 1.9-and 4.8-fold, respectively, in the presence of Gal-8. The stimulatory effect of Gal-8 on Treg and T H 2 differentiation was inhibited by TDG, a competing disaccharide that binds the CRD of galectins (Fig. 1A, B) , suggesting that the effect of Gal-8 on Treg and T H 2 differentiation was carbohydrate-dependent. Also, a trisaccharide, NeuAcα2-3Galβ1-4GlcNAc (α2,3-sialyllactose), which binds to the N-CRD of Gal-8, 18 inhibited Treg differentiation ( Fig. 2A) suggesting that the stimulatory effect of Gal-8 on Treg differentiation is mediated by binding to the 3′-sialylated glycoproteins on the CD4 + T cell surface. Gal-8 had no effect on T H 1 differentiation (Fig. 1C) , and reduced T H 17 polarization in a dose-dependent manner (Fig. 1D) . TDG alone was sufficient to inhibit T H 17 differentiation (Fig. 1D) 17 we focused our attention on characterizing the involvement of Gal-8 in Treg cell differentiation and function.
Results and Discussion

Gal-8 promotes Treg and T H 2 cell differentiation and inhibits differentiation of T H 17 cells in vitro
To determine whether Gal-8 promotes Ag-specific Treg cell polarization and to ensure that the observed increase in Treg polarization was not due to an artifact of stimulation with anti-CD3 and anti-CD28 mAbs, splenic OVA 323-339 -specific T cells from OT-II mice were incubated with OVA peptide-pulsed APCs (irradiated spleen cells) under Treg polarizing conditions in the presence or absence of Gal-8. In an Ag-specific context, the addition of 1.5 μM Gal-8 increased Treg cell differentiation three-fold in a carbohydrate-dependent manner (Fig. 2B) , confirming the results observed using anti-CD3-and anti-CD28-stimulated CD4 + T cells. Thus, Gal-8 induces both Ag-specific and polyclonal Treg cell differentiation.
Gal-8-polarized Treg cells express CTLA-4 and IL-10 at high frequency and suppress T cell proliferation
As described earlier, Treg cells suppress effector T cells. 15 The current study demonstrates that Gal-8
promotes Treg cell differentiation and function as well. Although most members of the galectin family bind galactose-containing residues, variability in the CRD among galectins results in unique fine specificities for more complex galactose-containing oligosaccharides. 23 As a result, each galectin may have profoundly different ligand preference based on glycosylation patterns, with consequent specific downstream effects. 19 , 24 , 25 In this respect, the carbohydrate-binding affinity of the N-terminal CRD of Gal-8 is unique among members of the galectin family in that it has a high affinity for 3′-sialylated glycoconjugates. 18 This unique carbohydrate specificity and structure could make Gal-8 a selective drug target.
Gal-8 activates the TGFβR signaling pathway and promotes sustained IL-2R signaling
Having established that Gal-8 promotes Treg cell differentiation in vitro, we performed studies to characterize the mechanism by which Gal-8 promotes Treg cell conversion. First, we tested whether Gal-8 binds to cell surface glycoproteins of naïve T cells and/or Treg cells. Splenic CD4 + CD62L hi CD44 lo naïve T cells and in vitro-polarized Treg cells were incubated with FITC-conjugated Gal-8 and mean fluorescence intensity (MFI) was measured by flow cytometry. Although Gal-8 bound both cell types, naïve T cells stained with a higher intensity at all doses of Gal-8 ( Fig. 4A) , indicating that Gal-8 ligands are To determine whether Gal-8 activates signaling pathways downstream of TGFβR and/or IL-2R, CD4 + T cells were incubated under Treg polarizing conditions for 0, 4, 24, or 72 hours in the presence or absence of 1.5 μM Gal-8. At the end of the incubation period, whole cell lysates were prepared and the phosphorylation status of Smad3 and STAT5 was evaluated by western blot analysis using phospho-specific antibodies. Gal-8 markedly increased phosphorylation of Smad3 at 4 h, which then decreased to the same extent as seen in control cells. In control cells, phosphorylation of STAT5 peaked at 24 h and declined to basal levels by 72 h. Exposure to Gal-8 resulted in sustained STAT5 phosphorylation over time; at 72 hours, STAT5 phosphorylation was as high as that detected at 24 h of incubation (Fig. 4C) . These results suggest that Gal-8 activates TGFβR signaling and sustains IL-2R signaling. The multivalency of galectins allows them to cross-link many cell surface receptors, including growth factor receptors and integrins, to regulate signal transduction pathways. 27 These postulated supramolecular galectin-ligand lattices have been shown to inhibit endocytosis, and the increased surface retention time can have a dramatic effect on receptor signaling. 27 , 28 Alternatively, galectins may directly ligate and activate their receptors independent of lattice formation. In this regard, Gal-9 promotes apoptosis of murine T H 1 cells through direct ligation of Tim-3, 29 and Gal-1 inhibits deactivation of microglia and prevents immune-mediated neurodegeneration by ligating microglial CD45 phosphatase. A recent study has shown that Gal-9 also supports Treg conversion by modulating TGFβ signaling. 9 It is known that in some cases, multiple galectins can influence the same function in a given cell type, although the mechanism, signaling pathways and glycan specificity may substantially differ for each family member. For example, Gal-1, -3, and -9 mediate the death of Jurkat cells by binding to distinct cell surface ligands. 30 
Methods
Mice C57BL/6J (B6) and OT-II mice were obtained from the Jackson Laboratory (Bar Harbor, ME, USA). Foxp3 mRFP IL-10 eGFP mice were a gift from J. Weinstock. 32 All animal study protocols conformed to the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Reagents, Ags, and Abs
The , and isotype controls. Antibodies and recombinant cytokines for T cell polarization were purchased from BioLegend (San Diego, CA, USA). Recombinant human glutathione S-transferase (GST) tagged Gal-8 was produced and purified from bacteria expressing GST-Gal-8 as previously described.
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In vitro CD4 + T cell differentiation CD4 + T cells were isolated from spleens by negative selection using the CD4 T Lymphocyte Enrichment Set (BD). Cells were stimulated for 96 h with 1 μg/ml anti-CD3 (145-2C11; BD) and 2 μg/ml anti-CD28 (37.51; BD) for polyclonal activation. Cells were differentiated to T H 1 by supplementation with 10 ng/ml IL-12 and 10 μg/ml anti-IL-4 mAb (11B11). T H 2 differentiation was induced by supplementation with 10 ng/ml IL-4 and 10 μg/ml anti-IFNγ mAb (XMG1.2). For T H 17 conversion, cells were supplemented with 20 ng/ml IL-6, 10 ng/ml IL-23, 1 ng/ml TGFβ1, and 10 ng/ml IL-1β in the presence of 10 μg/ml anti-IFNγ mAb and 10 μg/ml anti-IL-4 mAb. To induce Treg polarization, cells were incubated with 10 ng/ml TGFβ1, 1 ng/ml IL-2, and 1 ng/ml all-trans retinoic acid (Sigma, St. Louis, MO, USA). For Ag-specific activation, CD4 + T cells from OT-II mice were incubated with 20 μM OVA 323-339 in the presence of γ-irradiated CD4 − splenocytes under Treg polarizing conditions as above. For assessment of Gal-8 binding, naïve CD4 + T cells (CD4 + CD62L hi CD44 lo ) were prepared by FACS from spleens of B6 mice using an Influx Cell Sorter (BD).
Flow cytometry
Flow cytometry was performed as described previously 19 on a FACS Calibur (BD), and data were analyzed with FlowJo software (Tree Star, Ashland, OR, USA). Gates were set based on appropriate isotype controls. 
In vitro
Affinity precipitation assay
Affinity precipitation with Gal-8-conjugated agarose beads was performed as described previously. 34 Briefly, primary CD4 + T cell lysates were incubated with agarose-conjugated Gal-8 overnight at 4°C. Non-specific binding proteins were removed by washing, bound proteins were eluted by boiling the beads in Laemmli sample buffer, and assessed by western blotting.
Western blot analysis
Cell lysates were electrophoresed on SDS-PAGE gels (4-15% gradient polyacrylamide gels, BioRad, Hercules, CA, USA) and blots of the gels were probed with the following antibodies: anti-IL-2Rβ Novus, Littleton, CO, USA), anti-TGFβRII, anti-pSTAT5 (Tyr694), anti-STAT5, anti-pSmad3 (Ser423/Ser425), anti-Smad3, and anti-β-actin (all Cell Signaling, Beverly, MA, USA). The secondary Ab used were anti-rabbit IgG IRDye 800CW and antimouse IgG IRDye 680LT (LI-COR, Lincoln, NE, USA). Membranes were imaged using the Odyssey Infrared Imager and quantified using Image Studio v2.0 software (LI-COR).
Statistical analysis
Statistical analysis was performed using ANOVA with Tukey's test for multiple comparisons. P-values were considered statistically significant at p < 0.05 (*), p < 0.01 (**), p < 0.001 (***), p < 0.0001 (****). were collected at indicated times, probed for pSTAT5 and pSmad3, and each normalized to the appropriate non-phosphorylated control. Error bars represent mean ± SEM of at least three independent experiments. P values were determined by ANOVA with Tukey's multiple comparison test. **, p < 0.01.
